Tag: terms

New York, NY, July 10, 2025 (GLOBE NEWSWIRE) -- With the rapid development of cryptocurrencies in the past decade, the global financial landscape is undergoing an unprecedented transformation. In this wave, WinnerMining, an innovative smart cloud mining platform in the UK, stands out and is committed to providing global investors with convenient, safe and sustainable digital asset appreciation solutions, especially in terms of stable returns on popular currencies such as BTC、XRP and DOGE.



Simplify the mining process

WinnerMining provides digital currency mining services based on cloud computing power. Users do not need to purchase mining machines or configure power and cooling equipment. They only need to register conveniently through the official website or App to start the mining process with one click. It is easy to get started and there is no threshold to participate.

The platform supports a variety of mainstream currencies, including BTC, ETH, XRP, DOGE, USDT, etc. The contract period covers 1 to 90 days to meet the diversified strategy needs of different investors.

Safe and compliant, trustworthy

In order to ensure the security of user assets, WinnerMining uses McAfee and Cloudflare protection systems and decentralized hosting technology to protect user privacy and asset security. The platform currently covers 180+ countries and regions, and has won a good reputation worldwide. Its compliant operations are transparent and trustworthy.

Highlights of the platform

User-friendly interface: Newbies can quickly get started

Professional trading tools: Provide real-time viewing and contract management

Rich educational resources: Help users to deeply understand the market and strategy

Real-time monitoring system: View income and mining status at any time

24/7 customer support: Multi-language service channels, fast response

Sign up and get $15 computing power reward

New users can get $15 computing power reward for free when they register, and start their exclusive mining experience immediately. Daily income is automatically settled to achieve stable passive income.

Explore the future, join now

At a time when global inflationary pressure continues, the high interest rate cycle is extended, and the volatility of traditional financial markets is intensifying, more and more investors are beginning to seek alternative asset allocation methods with more stability and growth potential. Instead of letting digital assets idle and waiting for a rise, it is better to let them actively "work" to create continuous income. WinnerMining is reshaping the logic of cryptocurrency investment. With the help of green energy-driven intelligent cloud mining technology, it creates a low-threshold, high-efficiency, environmentally friendly and sustainable passive income platform for global users.

Official website: https://winnermining.com

APP download address: Click to download

Disclaimer:

The information contained in this article does not constitute investment advice, financial advice or trading recommendations. Cryptocurrency investment and mining have certain risks and may result in partial or total loss of funds. Users are advised to conduct full due diligence before investing and consult professional financial advisors.

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Flutter Entertainment (NYSE: FLUT; LSE: FLTR) (“Flutter”) the world’s leading online sports betting and iGaming operator today announces the extension of its long-term strategic partnership with Boyd Gaming Corporation (“Boyd”) to 2038 and the buyout of Boyd’s 5% stake in FanDuel Group (“FanDuel”), together “the Agreement”.

SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 102,350 shares of its common stock and granted an aggregate of 77,875 restricted stock unit (“RSU”) awards to 46 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).

SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the appointment of Marc. R Theoret, M.D. to assume the newly created position of Senior Vice President, Regulatory Strategy, where he will focus on clinical regulatory strategy for Iovance’s pipeline. Effective immediately, Dr. Theoret will report to Dr. Raj K. Puri, M.D., Ph.D., Chief Regulatory Officer.

WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously announced upsized underwritten public offering of 25,555,556 shares of its common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering. The public offering price was $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were sold by Cogent.

DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 5,242,464 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.763 per share of common stock (or per common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, SeaStar Medical will issue and sell unregistered warrants to purchase up to 5,242,464 shares of common stock. The warrants will have an exercise price of $0.638 per share, will be exercisable immediately upon issuance and will expire five years following the effective date of the resale registration statement registering the shares of common stock issuable upon exercise of the warrants.